Bicycle Therapeutics: Peers

The FY2024 (Dec) proxy of Bicycle Therapeutics names 19 peer companies for pay. Among Bicycle Therapeutics and these peers, CEO pay was the lowest of 9 and total shareholder return was 6th highest of 9.

9th highest of 9in Bicycle Therapeutics and its pay peers, FY2024 (Dec) by CEO pay:

$4.9M$18.8M

6th highest of 9in Bicycle Therapeutics and its pay peers, FY2024 (Dec) by total shareholder return:

$47$271

Pay peer group, FY2024 (Dec) proxy

TG Therapeutics
Ionis Pharmaceuticals
Intellia Therapeutics
Arvinas
Arcus Biosciences
Agios Pharmaceuticals
Beam Therapeutics
Cogent Biosciences
Blueprint Medicines CorporationNot disclosedNot disclosed
Deciphera Pharmaceuticals, Inc.Not disclosedNot disclosed
ImmunoGen, Inc.Not disclosedNot disclosed
Karuna Therapeutics, Inc.Not disclosedNot disclosed
Revance Therapeutics, Inc.Not disclosedNot disclosed
Rhythm PharmaceuticalsNot disclosedNot disclosed
Sage Therapeutics, Inc.Not disclosedNot disclosed
SpringWorks Therapeutics, Inc.Not disclosedNot disclosed
Syndax PharmaceuticalsNot disclosedNot disclosed
XencorNot disclosedNot disclosed
Zentalis Pharmaceuticals, Inc.Not disclosedNot disclosed
19 companies

Changes by year

No proxy on file names a change to the peer group.

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.